ERIC L ALBIN, M.D.
Osteopathic Medicine at 208 Ter, Miami, FL

License number
Florida ME 19605
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
3733 NE 208Th Ter, Miami, FL 33180
Phone
(305) 931-3337
(305) 937-4601 (Fax)

Personal information

See more information about ERIC L ALBIN at radaris.com
Name
Address
Phone
Eric Albin, age 80
3733 NE 208Th Ter, Miami, FL 33180
(305) 937-4601
Eric Albin, age 61
7117 Maxwell Ct, Panama City, FL 32404
(850) 874-0848
Eric L Albin, age 80
3733 208Th St, Opa Locka, FL 33180
(305) 931-3337
(305) 931-6827
(305) 937-4601
Eric S Albin, age 61
7117 Maxwell Ct, Callaway, FL 32404
(850) 874-0848
Eric S Albin, age 61
2976 Starfighter Ave, Panama City, FL 32403
(850) 286-2720

Professional information

See more information about ERIC L ALBIN at trustoria.com
Eric Albin Photo 1
Independent Investment Management Professional

Independent Investment Management Professional

Location:
Miami/Fort Lauderdale Area
Industry:
Investment Management


Eric Albin Photo 2
Skin Remodeling And Regenerative Compositions Containing Elastin Peptide Ligands Having The Amino Acid Sequence (Xgxxpg)N

Skin Remodeling And Regenerative Compositions Containing Elastin Peptide Ligands Having The Amino Acid Sequence (Xgxxpg)N

US Patent:
2005018, Aug 25, 2005
Filed:
Feb 24, 2004
Appl. No.:
10/785173
Inventors:
Eric Albin - Aventura FL, US
International Classification:
A61K038/10, A61K038/08, A61K007/11, A61K007/06
US Classification:
424070140, 514012000, 514014000, 514017000, 514023000
Abstract:
The present invention relates to skin care compositions providing a method of enhancing the remodeling of age damaged and sun damaged skin in mammals utilizing an elastin peptide (EP) ligand of the general formula (GXXPG)n and in particular the sequences of (VGVAPG)n and/or (GVAPGV)n, and/or (VAPGVG)n and/or (APGVGV)n and/or (PGVGVA)n and/or (GVGVAP)n and a galactosugar which modulates the effect of the elastin peptide ligand(EP) on its lectin the Elastin-Binding Receptor (EBR). wherin A is a peptide-forming residue of L-alanine; G is a peptide-forming residue of glycine P is a peptide-forming residue of L-proline V is a peptide-forming residue of L-valine X is a peptide-forming residue of a single unspecified amino acid Peptide representations in this application conform to the standard practice of writing the NH-terminal amino acid residue at the left of the formula and the COH-terminal amino acid residue at the right.